Clincosm LogoSign in Get a demo

hyperparathyroidism, secondary

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperparathyroidism, Secondary Trial in Sao Paulo (Subtotal Parathyroidectomy, Total Parathyroidectomy + 45 autografts, Total

Active, not recruiting
  • Hyperparathyroidism, Secondary
  • Subtotal Parathyroidectomy
  • +2 more
  • Sao Paulo, SP, Brazil
    University of Sao Paulo General Hospital
May 23, 2022

Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, Secondary Trial (Sodium zirconium cyclosilicate)

Completed
  • Sodium Zirconium Cyclosilicate
  • +2 more
  • Sodium zirconium cyclosilicate
  • (no location specified)
May 16, 2022

Postmenopausal Osteoporosis, Postmenopause, Hyperparathyroidism, Secondary Trial in Mexico City (Cholecalciferol)

Completed
  • Postmenopausal Osteoporosis
  • +4 more
  • Mexico City, Mexico
    Peri-postmenopause and bone metabolism clinic. Regional Hospital
Apr 30, 2022

Restless Leg Disorder, Renal Disease Bone, Renal Disease, End Stage Trial in Sao Paulo (Vitamin D, Placebo Oral Tablet)

Withdrawn
  • Restless Leg Disorder
  • +5 more
  • Vitamin D
  • Placebo Oral Tablet
  • Sao Paulo, SP, Brazil
    Hospital das Clinicas
Sep 29, 2021

Chronic Kidney Disease, Hyperparathyroidism, Hyperparathyroidism, Secondary Trial in Worldwide (cinacalcet capsule, , Standard

Terminated
Has Results
  • Chronic Kidney Disease
  • +4 more
  • cinacalcet capsule
  • +2 more
  • Birmingham, Alabama
  • +50 more
Jun 12, 2020

Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency Trial in Bannockburn (CTAP101 30 µg capsules, Sugar

Completed
Has Results
  • Chronic Kidney Disease
  • +2 more
  • CTAP101 30 μg capsules
  • Sugar pill to CTAP101 30 μg capsules
  • Bannockburn, Illinois
    OPKO Renal
Dec 17, 2019

Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency Trial in Bannockburn (CTAP101 30 µg capsules, Sugar

Completed
Has Results
  • Chronic Kidney Disease
  • +2 more
  • CTAP101 30 μg capsules
  • Sugar pill to CTAP101 30 μg capsules
  • Bannockburn, Illinois
    OPKO Renal
Dec 17, 2019

Study on the Use of Cinacalcet in Phosphocalcic Context.

Not yet recruiting
  • Hyperparathyroidism, Secondary
  • Hyperparathyroidism, Primary
  • Serum PTH concentrations results
  • Clermont-Ferrand, France
  • +9 more
Oct 11, 2019

Breast Cancer, Prostate Cancer, Bone Tumors Trial in United States (CTAP101 Capsules)

Completed
  • Breast Cancer
  • +4 more
  • CTAP101 Capsules
  • Long Beach, California
  • +5 more
Sep 25, 2019

Hyperparathyroidism, Secondary Trial in Worldwide (Etelcalcetide, Placebo)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Birmingham, Alabama
  • +117 more
Aug 9, 2019

Hyperparathyroidism, Secondary Trial in Worldwide (Etelcalcetide, Placebo)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Mobile, Alabama
  • +105 more
Aug 9, 2019

Hyperparathyroidism, Secondary Trial in Worldwide (Etelcalcetide)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Birmingham, Alabama
  • +208 more
Apr 1, 2019

Hyperparathyroidism, Secondary Trial in United States (Etelcalcetide)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Alhambra, California
  • +39 more
Sep 20, 2018

Hyperparathyroidism, Secondary Trial (Traditional Vitamin D Therapy, Cinacalcet)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • (no location specified)
Sep 20, 2018

Hyperparathyroidism, Secondary Trial in Australia, United States (Placebo, Etelcalcetide)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Cypress, California
  • +4 more
May 26, 2017

Hyperparathyroidism, Secondary Trial in Worldwide (Etelcalcetide)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Birmingham, Alabama
  • +228 more
Oct 18, 2017

Hyperparathyroidism, Secondary, Kidney Failure, Chronic Trial in United States (DP001 softgel capsules, Placebo)

Completed
  • Hyperparathyroidism, Secondary
  • Kidney Failure, Chronic
  • DP001 softgel capsules
  • Placebo
  • Phoenix, Arizona
  • +13 more
Aug 15, 2017

Roux-en-Y Gastric Bypass, Hyperparathyroidism, Secondary Trial in Aarhus (Calcium Carbonate, Calcium Citrate, Placebo)

Completed
  • Roux-en-Y Gastric Bypass
  • Hyperparathyroidism, Secondary
  • Calcium Carbonate
  • +3 more
  • Aarhus, Denmark
    Department of Enodocrinology and Internal Medicine, Aarhus Unive
Jun 23, 2017

Bone Microarchitecture With HR-pQCT of Chronic Kidney Disease

Completed
  • Chronic Kidney Diseases
  • Hyperparathyroidism, Secondary
  • HR-pQCT
  • DEXA
  • Saint-Etienne, France
    Chu Saint-Etienne
May 29, 2017

Hyperparathyroidism, Secondary Trial in Melbourne (Etelcalcetide, Placebo)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Melbourne, Victoria, Australia
    (unnamed)
Feb 28, 2017

Hyperparathyroidism, Secondary Trial in Bangkok (calcium sensing receptor agonist)

Completed
  • Hyperparathyroidism, Secondary
  • calcium sensing receptor agonist
  • Bangkok, Pathumwan, Thailand
    Chulalongkorn Memorial Hospital
Mar 27, 2017

Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency Trial (CTAP101 Capsules, Calcitriol,

Completed
Has Results
  • Chronic Kidney Disease
  • +2 more
  • CTAP101 Capsules
  • +3 more
  • (no location specified)
Aug 22, 2016

Hyperparathyroidism, Secondary, Kidney Failure, Chronic Trial in Durham (doxercalciferol)

Completed
Has Results
  • Hyperparathyroidism, Secondary
  • Kidney Failure, Chronic
  • Durham, North Carolina
    Duke University Medical Center Dialysis Unit
Jan 20, 2016

Hyperparathyroidism, Secondary Trial in San Fermo della battaglia (CO) (standard care, Optimal (I. iPTH control:

Unknown status
  • Hyperparathyroidism, Secondary
  • standard care
  • Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin D
  • San Fermo della battaglia (CO), Italy
    Azienda Ospedaliera Sant'Anna
Sep 12, 2015

RENAL INSUFFICIENCY, CHRONIC, Hyperparathyroidism, Secondary Trial in Homburg (Colecalciferol)

Completed
  • RENAL INSUFFICIENCY, CHRONIC
  • Hyperparathyroidism, Secondary
  • Homburg, Saarland, Germany
    University Hospital of Saarland, Dpt. of Internal Medicine IV, D
May 26, 2015